buserelin has been researched along with Lymph Node Metastasis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, ED; Anderson, TJ; Chetty, U; Forrest, AP; Hawkins, RA; Leonard, RC | 1 |
| Klarskov, P; Lund, F; Petersen, SE | 1 |
| Cheson, BD | 1 |
| Beacock, CJ; Buck, AC; Griffiths, K; Peeling, WB; Rees, RW; Turkes, A; Walker, K; Zwinck, R | 1 |
| Debruyne, FM | 1 |
| Ehrenthal, W; Hohenfellner, R; Jacobi, GH; Spindler, HW; von Wallenberg, H; Wenderoth, UK | 1 |
| Coombes, RC; Harland, SJ; Lister, TA; Malpas, JS; Powles, T; Waxman, JH; Wrigley, PF | 1 |
| Burk, K; Gropp, C | 1 |
4 trial(s) available for buserelin and Lymph Node Metastasis
| Article | Year |
|---|---|
Primary systemic therapy for operable breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Combined Modality Therapy; Female; Goserelin; Humans; Lymphatic Metastasis; Middle Aged; Ovariectomy; Tamoxifen | 1991 |
Secondary treatment of advanced cancer of the prostate with Zoladex.
Topics: Aged; Aged, 80 and over; Buserelin; Delayed-Action Preparations; Goserelin; Humans; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Remission Induction | 1990 |
Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.
Topics: Aged; Buserelin; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Orchiectomy; Prostatic Neoplasms; Remission Induction; Time Factors | 1988 |
Endocrine and clinical evaluation of 107 patients with advanced prostatic carcinoma under long-term pernasal buserelin or intramuscular decapeptyl depot treatment.
Topics: Adenocarcinoma; Administration, Intranasal; Antineoplastic Agents; Biomarkers, Tumor; Buserelin; Clinical Trials as Topic; Gonadotropin-Releasing Hormone; Humans; Injections, Intramuscular; Lymphatic Metastasis; Male; Neoplasm Staging; Prostatic Neoplasms; Time Factors; Triptorelin Pamoate | 1988 |
4 other study(ies) available for buserelin and Lymph Node Metastasis
| Article | Year |
|---|---|
Clinical trials referral resource. Adjuvant therapy of breast cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Carcinoma in Situ; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Goserelin; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Menopause; Middle Aged; Neoplasm Staging; Prognosis; Tamoxifen | 1989 |
The treatment of metastatic prostatic cancer with the slow release LH-RH analogue Zoladex ICI 118630.
Topics: Acid Phosphatase; Aged; Alkaline Phosphatase; Bone Neoplasms; Buserelin; Delayed-Action Preparations; Goserelin; Humans; Luteinizing Hormone; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Random Allocation; Testosterone | 1987 |
The treatment of postmenopausal women with advanced breast cancer with buserelin.
Topics: Adenocarcinoma; Aged; Breast Neoplasms; Buserelin; Female; Gonadotropins, Pituitary; Humans; Hypophysectomy, Chemical; Lymphatic Metastasis; Menopause; Middle Aged; Time Factors | 1985 |
[What is safe in the therapy of advanced prostatic cancer?].
Topics: Androgen Antagonists; Antineoplastic Agents; Buserelin; Combined Modality Therapy; Estradiol Congeners; Estramustine; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Lymphatic Metastasis; Male; Neoplasm Staging; Orchiectomy; Prognosis; Prostate; Prostatectomy; Prostatic Neoplasms | 1985 |